USA flag logo/image

An Official Website of the United States Government

Search


Download to spreadsheetPrint
Displaying 51 – 75 of 1244 Awards
Company: VISDEX CORPORATION Agency/Program/Year/Phase: HHS / STTR / 2013 / 2
Abstract: …ster automated platform for application to commercialspectral domain (SD-OCT) systems; (2) optimize optical scanner performance for imaging both dilated and non-dilated pupils; and (3) demonstrate the feasibility of PC-OCT as a wide-field screening diagnostic for diabetic… more
Company: VISIONQUEST BIOMEDICAL, LLC Agency/Program/Year/Phase: HHS / SBIR / 2013 / 1
Abstract: … age 50 and older have advanced AMD, the stage that can lead to severe vision impairment and 10 million have early or intermediate AMD. Glaucoma affects more than 2.3 million Americans age 40 and older. Another two million individuals with glaucoma are undiagnosed. Diabetes… more
Company: MOLECULAR EXPRESS, INC. Agency/Program/Year/Phase: HHS / SBIR / 2013 / 1
Abstract: … RELEVANCE: Acute kidney injury (AKI) affects more than 10 million people worldwide per year with 15-60% mortality. However, methods for early diagnosis of AKI are still lacking and consequently this is one of the research topics solicited by the National Institute of … more
Company: ENERGESIS PHARMACEUTICALS, INC. Agency/Program/Year/Phase: HHS / SBIR / 2013 / 1
Abstract: DESCRIPTION (provided by applicant): Obesity has reached epidemic proportions in the U.S. and plays a major role in the development of type 2 diabetes, dyslipidemia, and cardiovascular disease. There remains a very significant need for better non- surgicaltreatments. While most… more
Company: CYTOSOLV INC. Agency/Program/Year/Phase: NSF / SBIR / 2013 / 1
Abstract: … growth factor cocktail for application to biologic hernia meshes to treat the challenging hernia repair market. CP factors represent a broad spectrum of potent biologic molecules that have demonstrated a benefit in the healing of splinted open wounds in diabetic mice, are… more
Company: RADIKAL THERAPEUTICS, INC. Agency/Program/Year/Phase: HHS / SBIR / 2013 / 1
Abstract: DESCRIPTION (provided by applicant): We are developing a novel immunomodulatory approach to arrest pancreatic islet injury and restore specific immune tolerance in new-onset Type 1 diabetes mellitus (T1D). Damage of pancreatic islets in T1D may result fromexcess pathogenic… more
Company: RADIKAL THERAPEUTICS, INC. Agency/Program/Year/Phase: HHS / SBIR / 2013 / 1
Abstract: … from 90% to 50% (plt0.01). In a murine RIRI model, 24 h creatinine elevations were entirely eliminated by a single dose of R-100 prior to reperfusion (plt0.01). Aim #1: Establish the pharmacodynamic (PD) profile of R-100 in models of CIN in healthy and diabetic rodents… more
Company: ADVANCED PLASMA PRODUCTS, INC. Agency/Program/Year/Phase: HHS / SBIR / 2013 / 2
Abstract: DESCRIPTION (provided by applicant): Annually, 5 to 7 million Americans are treated for chronic wounds that arise from diabetes, lower extremity arterial disease, lower extremity venous disease, pressure ulcers, and traumatic injuries, including burns, demonstrating the need for… more
Company: LUCERNA, INC. Agency/Program/Year/Phase: HHS / SBIR / 2013 / 1
Abstract: … (ARDTs) are two families of related enzymes that have important medically relevant functions. For example, SIRT3, a mitochondrial sirtuin, controls mitochondrial function, and thereby exerts a strong effect on metabolism, obesity, type 2 diabetes, and… more
Company: ION CHANNEL INNOVATIONS, LLC Agency/Program/Year/Phase: HHS / SBIR / 2013 / 2
Abstract: … the hSlo gene splice variant, called hMaxiK, which codes for the pore forming subunit of the large conductance potassium channel. Prior studies by ICI have shown that hMaxiK improves urogenital pathophysiology in rodent and nonhuman primate models of aging, diabetes and… more
Company: HAGER BIOSCIENCES, INC. Agency/Program/Year/Phase: HHS / SBIR / 2013 / 1
Abstract: … (PARP-1) areuseful neuroprotective agents especially when the neurodegeneration is caused by excitotoxic insult. Inhibitors of PARP-1 have been investigated pre-clinically and clinically for cardiac ischemia, hemorrhagic shock syndrome, stroke, traumatic CNS injury,diabetes,… more
Company: NEURO DEVICES, INC. Agency/Program/Year/Phase: HHS / STTR / 2013 / 2
Abstract: DESCRIPTION (provided by applicant): We devised a new generation, highly sensitivity method to diagnosis peripheral neuropathy early, when the probability for reversal is greatest. Cancer chemotherapy and diabetes are the most common causes of neuropathy in the USA. Both cause… more
Company: NEURO DEVICES, INC. Agency/Program/Year/Phase: HHS / STTR / 2013 / 2
Abstract: … low micron levels. The objectives are to diagnose peripheral neuropathy near its onset, when the possibility for reversal is highest, and to monitor either progression or reversal of neuropathy during treatment. Target neuropathies are those related to chemotherapy and diabetes… more
Company: HYGIEIA RESEARCH, LLC Agency/Program/Year/Phase: HHS / STTR / 2013 / 2
Abstract: DESCRIPTION (provided by applicant): According to UnitedHealth14 by 2020 half of all Americans would have either diabetes or pre-diabetes with an annual cost of 500 billion - mainly attributed to diabetes related complications. Diabetes is a growing epidemic… more
Company: MARKER GENE TECHNOLOGIES Agency/Program/Year/Phase: HHS / SBIR / 2013 / 1
Abstract: …esearch will provide breakthroughs needed to advance the discovery of promising new therapies and modulating drugs for neurodegenerative disorders including Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), Parkinson's disease(PD), Type 2 diabetes, Lowe… more
Company: eLutions Integrated Systems, Inc. Agency/Program/Year/Phase: NSF / SBIR / 2013 / 1
Abstract: … in concentration over time in biological tissues, such as in the interstitial fluid and in the blood. The objectives of this project are to miniaturize an existing Raman bench-top system to one that is wearable, low-cost, and optimized for blood glucose measurement in diabetic… more
Company: VERISTRIDE, Inc. Agency/Program/Year/Phase: NSF / SBIR / 2013 / 2
Abstract: … impact/commercial potential of this project includes the focus on mobility limitations in persons with lower-limb amputations, which affect twice as many minorities as Caucasians. The commercial potential of this wireless assistive technology is vast: with diabetes as the… more
Company: CYTOVAS, LLC Agency/Program/Year/Phase: HHS / SBIR / 2013 / 1
Abstract: … a number of conditions where vascular dysfunction and inflammation are important pathophysiological mechanisms, for example coronary artery disease or thrombotic microangiopathies. We recently completed apilot study evaluating levels of MPs in patients with diabetes mellitus… more
Company: INTELLIGENT OPTICAL SYSTEMS, INC. Agency/Program/Year/Phase: HHS / SBIR / 2013 / 2
Abstract: … by applicant): Project Summary Accurate quantification of alcohol and drugs of abuse intoxication in emergency rooms (ERs) is an important screening step for a precise diagnosis and hence for prompt treatment. Some severe emergenciessuch as traumatic head injury, diabetes… more
Company: AGAVE BIOSYSTEMS Agency/Program/Year/Phase: HHS / STTR / 2013 / 1
Abstract: … molecular, cellular and physiological changes of endocrine FGF activity modulation will be verified. This translational research project for therapeutic target validation will lead to the development of potential new drugs against chronic kidney disease, diabetes, obesity… more
Company: Metabolic Technologies, Inc. Agency/Program/Year/Phase: NSF / SBIR / 2013 / 1
Abstract: … supply shortage worldwide. Data suggest that omega-3 fatty acids, such as DHA, play important roles in enhancing heart health, brain health, child and infant development and preventing various chronic diseases, such as rheumatoid arthritis, obesity and type-2 diabetes. It is… more
Company: MEDIKINE, INC. Agency/Program/Year/Phase: HHS / SBIR / 2013 / 1
Abstract: … the peptides in a form suitable for direct testing for cytokine receptor activation in ultra-high-throughput formats. The resulting functional assays are designed to identify peptides with new cytokine-like properties useful for many therapeutic applications in diabetes,… more
Company: AVANSCI BIO, LLC Agency/Program/Year/Phase: HHS / SBIR / 2013 / 2
Abstract: DESCRIPTION (provided by applicant): Microscopic analysis of tissue mounted on glass slides is commonly used to study cancer, non-neoplastic entities such as heart disease and diabetes, and normal cell function. Researchers utilize micro and macro tissue dissection techniques in… more
Company: COLLAGEN MEDICAL, LLC Agency/Program/Year/Phase: HHS / SBIR / 2013 / 2
Abstract: DESCRIPTION (provided by applicant): Dramatic increases in the incidence of obesity, diabetes, and the metabolic syndrome are increasing the prevalence of chronic liver diseases. Liver fibrosis arising from an excessive deposition of type I collagen in theparenchyma, occurs in… more
Company: Advanced Polymer Monitoring Technologies, Inc. Agency/Program/Year/Phase: NSF / SBIR / 2013 / 1
Abstract: … and quality control dimensions and accelerate development of new drugs while making existing ones safer and more efficiently produced. The technology can be used wherever proteins are under development for fighting diseases such as cancer, Alzheimer's, diabetes, and… more
Displaying 51 – 75 of 1244 Awards
Narrow Your Search
By Agency
By Year
By Phase
By Program
By State
By Company Ownership
By Company
HELP FOR NARROW YOUR SEARCH

Search Options

There are several categories such as “By Agency”, “By Year”, “By State” etc. Select a checkbox within a category to refine your search results.

Each of your selections is listed in the “Narrow Search Filters” bar. You can uncheck these selections to remove them.


Search for Either Criteria

When you select multiple values within a category, the results will include values that match either of the selections. For example, selecting “2005” and “2007” in the “By Year” category will display results that include either 2005 OR 2007 in the results.


Narrowing the Search Results

You can refine your search results across categories. To narrow down your results, select multiple values across different categories. The results will only include values that match the selections across the categories. For example, selecting “2005” in the “By Year” category and “NASA” in the “By Agency” category will only display the results that contain both “2005” AND “NASA” in the results.